News from prime therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 14, 2015, 08:00 ET

Prime Therapeutics names Jim DuCharme president and CEO

 Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving more than 26 million members, announced today...

Apr 06, 2015, 11:37 ET

New Cystic Fibrosis Treatments May Significantly Increase Pharmacy Benefit Costs

 Ground-breaking new cystic fibrosis treatments, that target the gene mutations causing the disease, will significantly increase health care...

Apr 06, 2015, 11:25 ET

Study: Drug Costs for Rare Hereditary Angioedema Disorder Tripled in Two Years

Hereditary angioedema (HAE) – a rare genetic disorder that results in potentially life-threatening edema or swelling of limbs,...

Apr 06, 2015, 11:19 ET

Prime Therapeutics Study Finds Many People May Take Opioids Inappropriately

Even though medical guidelines recommend against prolonged opioid use for conditions such as low back pain, headaches and fibromyalgia, many people...

Mar 18, 2015, 14:00 ET

First full-year look at public exchange member drug usage released by Prime Therapeutics

During the first year public health exchanges existed, Prime Therapeutics' (Prime) members who enrolled in plans on...

Mar 06, 2015, 11:35 ET

Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed

 Prime Therapeutics LLC (Prime), a non-profit pharmacy benefit manager serving more than 26 million members, today released the following...

Mar 03, 2015, 12:07 ET

Prime Therapeutics receives PBMI's 2015 Rx Innovation Award

Prime Therapeutics LLC (Prime) received the Pharmacy Benefit Management Institute's (PBMI) 2015 Rx Innovation Award today in...

Feb 24, 2015, 09:00 ET

Great Expectations for U.S. Biosimilars, But Prime Therapeutics Warns Regulatory Decisions May Reduce Savings

 The imminent approval of the first biosimilars in the U.S. brings widespread optimism that they will stem the tide of soaring specialty drug...

Feb 16, 2015, 14:00 ET

Prime Therapeutics study links controlled substances score to health outcomes, cost of care

In the past decade, drug overdose deaths have more than doubled and over 50 percent were related to prescription drugs.1 To help curb this...

Jan 12, 2015, 14:00 ET

Prime Therapeutics Breaks from Competition, Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs

 People with Hepatitis C who are served by pharmacy benefit manager Prime Therapeutics LLC (Prime) will now have...

Dec 09, 2014, 10:29 ET

Prime Therapeutics Joins the National Association of Specialty Pharmacy (NASP) as a Founding Corporate Member

The National Association of Specialty Pharmacy™ (NASP™) announced today Prime Therapeutics LLC (Prime) joined the association as a...

Dec 04, 2014, 12:04 ET

Prime Therapeutics wins 2014 National Health Care Anti-Fraud Association Investigative Excellence Award

 Prime Therapeutics LLC (Prime) was named the winner of the 2014 National Health Care Anti-Fraud Association (NHCAA) Investigative Excellence...

Dec 02, 2014, 09:00 ET

Prime Therapeutics Specialty Pharmacy achieves 95 percent member satisfaction

It's no surprise people living with complex illnesses such as rheumatoid arthritis can improve their quality of life by...

Dec 01, 2014, 12:50 ET

Prime Therapeutics Specialty Pharmacy to add nearly 100 jobs in Orlando

 One Orlando company has nearly doubled the size of its staff in the last two years.  And, it's adding approximately 100 more jobs by the...

Nov 17, 2014, 16:31 ET

Prime Therapeutics wins Stevie® Awards for Women in Business

Ingrid Lindberg, chief customer experience officer at Prime Therapeutics LLC (Prime), and her teams were named winners of two2014 Stevie®...

Oct 10, 2014, 15:13 ET

Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug

 Today's U.S. Food and Drug Administration (FDA) approval of Gilead's new, fixed-dose, combination Hepatitis C drug signals another spike...

Oct 09, 2014, 11:06 ET

Duane Barnes, Prime Therapeutics' COO, Joins NASP / SPAARx Board of Directors

 The National Association of Specialty Pharmacy (NASP) / Specialty Pharmacy Association of America (SPAARx) announced today that Duane Barnes,...

Oct 06, 2014, 16:53 ET

Prime Therapeutics, Johns Hopkins publish research on specialty drug copay coupons in Health Affairs

Today, the journal Health Affairs published its October issue focused on specialty medicines and included an article on copay...

Oct 06, 2014, 09:00 ET

Blue Cross Blue Shield Association and Prime Therapeutics Study Demonstrates Health Benefits and Cost Savings of Pharmacy Benefit Integration within Insurance Plans

Blue Cross Blue Shield Association (BCBSA) and Prime Therapeutics LLC (Prime) today released a study demonstrating clear health benefits and cost...

Sep 30, 2014, 09:00 ET

Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs

In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g. opioids).1 Clinical treatments for opioid...